Understanding Mast Cell Disease

What is a Comorbidity?

Allergic & Immunologic

Chronic spontaneous urticaria (chronic hives)

Chronic spontaneous urticaria, or CSU, is a condition where itchy, raised bumps (called hives) keep coming back for more than six weeks, often for no clear reason. It affects about 1 in 100 people and is most common in women between ages 20 and 40. Many people think their hives are caused by certain foods, but for almost everyone with CSU, food is not the problem. Sometimes the body’s own immune system causes the hives by mistake, and sometimes thyroid problems play a role, but in most cases doctors can’t find a specific cause.

To figure out if you have CSU, a doctor (usually an allergist) will ask about your health history, your family’s health, and any medicines you take. Blood tests can help the doctor understand what might be causing your hives and decide on the best treatment. There is no single test that can confirm CSU on its own. Instead, doctors look at whether your hives have lasted more than six weeks and rule out other possible reasons for them.

Treatment usually starts with antihistamines, which are medicines that block the chemicals causing the hives and itching. If those don’t work well enough, even at higher doses, there are stronger medicines available that target the immune system in different ways. Some are given as shots and others are pills. In tough cases, doctors may try medicines that help calm down an overactive immune system.

IgE-mediated allergy

Your body can overreact to something specific like peanuts or bee stings. It can cause hives, flushing, and a dangerous drop in blood pressure.

Anaphylaxis

This is a serious whole-body reaction that can affect breathing and blood pressure. People with mast cell disease have a higher chance of this, so care teams plan ahead for safety.

Hereditary alpha-tryptasemia

Some people are born with a gene that makes their tryptase naturally high even when they feel fine. Since high tryptase is a main clue for mast cell disease, care teams need to know if yours is just naturally high before interpreting results.

Musculoskeletal

Weak bones (osteopenia & osteoporosis)

Bones can become thinner and break more easily over time. People with systemic mast cell disease may have a higher risk of this, even if they have mild disease. The exact reason for this is not fully understood.

Hypermobile Ehlers-Danlos syndrome (hEDS)

This is a connective tissue disorder with some features that overlap with mast cell diseases. Individuals with hypermobile EDS have overly flexible joints, joint pain, and fatigue.

Gastrointestinal

Gastroesophageal reflux (GERD)

This is when stomach acid travels back up into the food pipe, causing heartburn and discomfort. It can add to gut symptoms in mast cell disease.

Irritable bowel syndrome (IBS)

IBS makes the gut extra sensitive and causes cramping, bloating, and diarrhea. Changes in diet, stress management, and medications are often part of the treatment for IBS.

Cardiovascular & Autonomic

Postural orthostatic tachycardia syndrome (POTS)

When someone with POTS stands up, their heart races and they feel dizzy. Individuals with POTS may faint when they stand, especially when they get up quickly or from a lying down position.

Neurologic

Migraines

These are severe headaches that can cause throbbing pain, nausea, and sensitivity to light and sound. They can last for hours or even days and can be triggered by things like food, stress, or changes in sleep in some individuals.

Mental Health

Cognitive Dysfunction

This involves trouble thinking clearly, finding the right words, or remembering things even when they are feeling otherwise well. Cognitive dysfunction is often called “brain fog”.

Anxiety

Anxiety is when a person feels worried, scared, or on edge much more than usual. It can make the body feel physical symptoms like a racing heart or upset stomach on top of everything mast cell disease is already causing.

Depression

Depression is when a person feels persistently sad, empty, or without interest in things they used to enjoy. It goes beyond ordinary sadness in a way that affects daily life and adds to the emotional weight of living with a chronic illness.

References

Source citations as provided in the approved content document. Numbering is preserved exactly as supplied.

  1. American College of Asthma, Allergy, and Immunology. Chronic Spontaneous/Idiopathic Urticaria (Chronic hives). Accessed April 4, 2026. https://acaai.org/allergies/allergic-conditions/skin-allergy/chronic-hives/
  2. Tbakhi B, Ware K, Park HS, Bernstein JS, Bernstein JA. An Overview of Chronic Spontaneous Urticaria: Diagnosis, Management, and Treatment. Allergy Asthma Immunol Res. 2025;17(5):531-546. doi:10.4168/aair.2025.17.5.531
  3. Li JY, Ryder CB, Zhang H, et al. Review and Updates on Systemic Mastocytosis and Related Entities. Cancers. 2023;15(23):5626. doi:10.3390/cancers15235626
  4. Valent P, Akin C. Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction. J Allergy Clin Immunol Pract. 2019;7(4):1109-1114. doi:10.1016/j.jaip.2018.11.045
  5. Ługowska-Umer H, Czarny J, Rydz A, Nowicki RJ, Lange M. Current Challenges in the Diagnosis of Pediatric Cutaneous Mastocytosis. Diagnostics. 2023;13(23):3583. doi:10.3390/diagnostics13233583
  6. Valent P, Akin C, Bonadonna P, et al. Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome. J Allergy Clin Immunol Pract. 2019;7(4):1125-1133.e1. doi:10.1016/j.jaip.2019.01.006
  7. El Hussein S, Chifotides HT, Khoury JD, Verstovsek S, Thakral B. Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update. Cancers. 2022;14(14):3474. doi:10.3390/cancers14143474
  8. Syal A, Toh J, McInerney A, Tremblay D. The evaluation, management, and future of indolent systemic mastocytosis. Ann Hematol. 2025;104(8):3917-3927. doi:10.1007/s00277-025-06475-y
  9. Valent P, Carter M. Diagnosis, Prognostication, and Management of Patients With Mastocytosis: Status 2026. J Allergy Clin Immunol Pract. 2026;14(1):53-55. doi:10.1016/j.jaip.2025.10.042
  10. Brockow K, Bent RK, Schneider S, et al. Challenges in the Diagnosis of Cutaneous Mastocytosis. Diagnostics. 2024;14(2):161. doi:10.3390/diagnostics14020161
  11. Ustun C, Keklik Karadag F, Linden MA, Valent P, Akin C. Systemic Mastocytosis: Current Status and Challenges in 2024. Blood Adv. Published online January 24, 2025:bloodadvances.2024012612. doi:10.1182/bloodadvances.2024012612
  12. Bonamichi-Santos R, Yoshimi-Kanamori K, Giavina-Bianchi P, Aun MV. Association of Postural Tachycardia Syndrome and Ehlers-Danlos Syndrome with Mast Cell Activation Disorders. Immunol Allergy Clin North Am. 2018;38(3):497-504. doi:10.1016/j.iac.2018.04.004
  13. Afrin LB, Self S, Menk J, Lazarchick J. Characterization of Mast Cell Activation Syndrome. Am J Med Sci. 2017;353(3):207-215. doi:10.1016/j.amjms.2016.12.013
  14. Kurin M, Elangovan A, Alikhan MM, et al. Irritable bowel syndrome is strongly associated with the primary and idiopathic mast cell disorders. Neurogastroenterol Motil. 2022;34(5):e14265. doi:10.1111/nmo.14265
✕
Skip to content